C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 8,262 | 8,447 | 9,670 | 6,816 | 0 |
| Gross Profit | 8,262 | 8,447 | 9,670 | 6,816 | N/A |
| Operating Expenses | 27,165 | 26,796 | 20,529 | 19,154 | 0 |
| Operating Income | -18,903 | -18,349 | -10,859 | -12,338 | N/A |
| Interest Expense | 481 | 512 | 102 | -259 | 0 |
| Other Income | -2,535 | -3,141 | 0 | 0 | 0 |
| Pre-tax Income | -21,919 | -22,002 | -10,961 | -12,079 | 0 |
| Income Tax | -124 | -167 | -168 | -167 | N/A |
| Net Income Continuous | -21,795 | -21,835 | -10,793 | -11,912 | N/A |
| Net Income | $-21,795 | $-21,835 | $-10,793 | $-11,912 | $N/A |
| EPS Basic Total Ops | 30.59 | -17.55 | -9.28 | -9.59 | N/A |
| EPS Basic Continuous Ops | 23.79 | -14.17 | -7.31 | -8.14 | N/A |
| EPS Diluted Total Ops | 30.59 | -17.55 | -9.28 | -9.59 | N/A |
| EPS Diluted Continuous Ops | 23.79 | -14.17 | -7.31 | -8.14 | N/A |
| EBITDA(a) | $-18,461 | $-17,717 | $-10,418 | $-11,922 | $N/A |